Screener
LABU vs HIBS
Direxion Daily S&P Biotech Bull 3X Shares vs Direxion Daily S&P 500 High Beta Bear 3X Shares
Key differences
- LABU costs 0.10% less per year.
- LABU is significantly larger than HIBS — larger funds tend to be more liquid and less likely to close.
- LABU follows a leveraged strategy; HIBS uses inverse.
- Over the last 3 years, LABU has delivered higher annualized returns.
Side-by-side comparison
| LABU | HIBS | |
|---|---|---|
| Annual cost (TER) | 0.96% | 1.06% |
| Fund size (AUM) | $528M | $19M |
| Since | 2015 | 2019 |
| Dividend yield | 0.69% | 7.92% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | inverse |
| CAGR 1Y | +246.3% | -80.6% |
| CAGR 3Y | +10.2% | -62.8% |
| CAGR 5Y | -32.0% | -52.3% |
| Sharpe 3Y | 0.48 | -0.97 |
| Volatility 1Y | 75.02% | 67.54% |
| Max drawdown | -98.96% | -99.98% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to LABU and HIBS
Explore further